On the evening of September 29, Yabao Pharmaceutical announced that Suzhou Yabao, the holding company, received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration for additional indications of SY-009 capsules, and approved the application for SY-009 capsules to conduct phase II clinical trials for functional constipation.

Zhitongcaijing · 4d ago
On the evening of September 29, Yabao Pharmaceutical announced that Suzhou Yabao, the holding company, received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration for additional indications of SY-009 capsules, and approved the application for SY-009 capsules to conduct phase II clinical trials for functional constipation.